Bioparox (fusafungine) was long considered a staple in Ukrainian medicine cabinets for treating upper respiratory tract infections. Known for its distinct aromatic scent and dual action, it was a go-to for many. However, if you are looking for Bioparox today, there are critical updates regarding its availability and safety that you need to know. What was Bioparox used for?
For symptomatic relief of throat pain. Isla-Moos: Herbal lozenges to soothe the mucosa.
Clearing nasal passages during bacterial infections. Laryngitis: Treating inflammation of the vocal cords. Instruction for Use (Historical Reference)
Bioparox was an inhaled antibiotic and anti-inflammatory spray. It was primarily prescribed for:
If you still have an old bottle of Bioparox in your first-aid kit, it is highly recommended to . Not only is it likely expired, but the safety risks mentioned above remain. Always consult with a healthcare professional before starting any new treatment for respiratory issues.
As of 2016, the followed the recommendations of the European Medicines Agency (EMA) and revoked the registration of Bioparox. The decision was based on a safety review which found:
Bioparox (fusafungine) was long considered a staple in Ukrainian medicine cabinets for treating upper respiratory tract infections. Known for its distinct aromatic scent and dual action, it was a go-to for many. However, if you are looking for Bioparox today, there are critical updates regarding its availability and safety that you need to know. What was Bioparox used for?
For symptomatic relief of throat pain. Isla-Moos: Herbal lozenges to soothe the mucosa.
Clearing nasal passages during bacterial infections. Laryngitis: Treating inflammation of the vocal cords. Instruction for Use (Historical Reference)
Bioparox was an inhaled antibiotic and anti-inflammatory spray. It was primarily prescribed for:
If you still have an old bottle of Bioparox in your first-aid kit, it is highly recommended to . Not only is it likely expired, but the safety risks mentioned above remain. Always consult with a healthcare professional before starting any new treatment for respiratory issues.
As of 2016, the followed the recommendations of the European Medicines Agency (EMA) and revoked the registration of Bioparox. The decision was based on a safety review which found: